BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31049654)

  • 21. Defibrillators: Selecting the Right Device for the Right Patient.
    Al-Khatib SM; Friedman P; Ellenbogen KA
    Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie.
    Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
    Arch Cardiovasc Dis; 2016 Oct; 109(10):563-585. PubMed ID: 27595465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with pacemaker or implantable cardioverter-defibrillator.
    Schulman PM; Rozner MA; Sera V; Stecker EC
    Med Clin North Am; 2013 Nov; 97(6):1051-75. PubMed ID: 24182719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical Techniques, Complications, and Long-Term Health Effects of Cardiac Implantable Electronic Devices.
    Richardson CJ; Prempeh J; Gordon KS; Poyser TA; Tiesenga F
    Cureus; 2021 Jan; 13(1):e13001. PubMed ID: 33659133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A practical approach to device interrogation].
    Rubesch-Kütemeyer V
    Herzschrittmacherther Elektrophysiol; 2022 Mar; 33(1):98-107. PubMed ID: 35147765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
    Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
    Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why We Need Postmortem Analysis of Cardiac Implantable Electronic Devices.
    Mauf S; Jentzsch T; Laberke PJ; Thali MJ; Bartsch C
    J Forensic Sci; 2016 Jul; 61(4):988-92. PubMed ID: 27364278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on Cardiovascular Implantable Electronic Devices for Anesthesiologists.
    Cronin B; Essandoh MK
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1871-1884. PubMed ID: 29217253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End of life decisions in heart failure: to turn off the intracardiac device or not?
    Ayach B; Malik A; Seifer C; Zieroth S
    Curr Opin Cardiol; 2017 Mar; 32(2):224-228. PubMed ID: 28079553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical considerations for turning off pacemakers and defibrillators.
    Karches KE; Sulmasy DP
    Card Electrophysiol Clin; 2015 Sep; 7(3):547-55. PubMed ID: 26304534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness.
    Groeneveld PW; Dixit S
    Annu Rev Med; 2017 Jan; 68():1-13. PubMed ID: 27686020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deactivation of pacemakers and implantable cardioverter-defibrillators.
    Kramer DB; Mitchell SL; Brock DW
    Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac implantable electronic device reutilization: battery life of explanted devices at a tertiary care center.
    Gakenheimer L; Romero J; Baman TS; Montgomery D; Smith CA; Oral H; Eagle KA; Crawford T
    Pacing Clin Electrophysiol; 2014 May; 37(5):569-75. PubMed ID: 24359248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in cardiac implantable electronic device infection prevention: should we push the envelope?
    Lambert CT; Wilkoff BL; Tarakji KG
    Future Cardiol; 2018 Sep; 14(5):359-366. PubMed ID: 30062906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality dying: An approach to ICD deactivation in the hospital setting.
    Turner S; Torabi S; Stilos K
    Am J Hosp Palliat Care; 2020 Sep; 37(9):664-668. PubMed ID: 32126793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Device Management in Heart Failure.
    Angel BG; Saltzman H; Kusmirek LS
    Curr Cardiol Rep; 2017 Sep; 19(11):114. PubMed ID: 28948481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.